Spruce Street Capital »

Alector shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Alector (ALEC) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Alector

Tip: Access up to 7 years of quarterly data

All positions including Alector held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alector by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.2M 2.1M 2.01

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Alector

TCG Crossover Management
BlackRock
Acadian Asset Management
Foresite Capital Management IV
Vanguard Capital Management
Merck & Co
D. E. Shaw & Co
683 Capital Management
Balyasny Asset Management
Nantahala Capital Management
Vanguard Portfolio Management
Geode Capital Management
Jacobs Levy Equity Management
Spruce Street Capital
Ikarian Capital

View all funds holding Alector